The Royal Australian College of General Practitioners (RACGP) is grateful for comments from the organisations endorsing the guidelines, and
Associate Professor Chris Bullen, Director, Clinical Trials Research, National Institute of Health Innovation, The University of Auckland, New Zealand
Dr Colin Mendelsohn, general practitioner and Vice President, Australian Association of Smoking Cessation Professionals, Sydney, New South Wales.
Dr Tim Senior, RACGP National Faculty of Aboriginal and Torres Strait Islander Health.
The RACGP would like to thank the following content advisors who contributed to the July 2014 update of the guidelines:
Professor Nicholas Zwar (Chair), School of Public Health and Community Medicine, UNSW Australia
Professor Robyn Richmond, School of Public Health and Community Medicine, UNSW Australia
Dr Ron Borland, Cancer Council Victoria
Professor Matthew Peters, Respiratory Medicine, Concord Hospital
Mr Joey Calandra, Pharmaceutical Society of Australia
Ms Marion Goodman, Australian Primary Health Care Nurses Association
Dr Terry Evans, Quit South Australia
Dr Colin Mendelsohn, Australian Association of Smoking Cessation Professionals
Statements of competing interests
Dr Ron Borland has developed QuitCoach and onQ smoking cessation programs, although he has no commercial interest in them.
Associate Professor John Litt has provided smoking cessation advice and training at meetings supported by Pfizer Pty Ltd and is a member of the varenicline advisory board for Pfizer Pty Ltd.
Associate Professor Matthew Peters has received honoraria from Pfizer Pty Ltd for contribution to the varenicline advisory board and for CME lectures at meetings supported by Pfizer Pty Ltd.
Professor Nicholas Zwar has provided expert advice on smoking cessation education programs to Pfizer Pty Ltd and GlaxoSmithKline Australia Pty Ltd and has received support to attend smoking cessation conferences.
Dr Colin Mendelsohn has received honoraria for teaching, consulting and conference expenses from Pfizer Pty Ltd, GlaxoSmithKline Australia Pty Ltd and Johnson & Johnson Pacific Pty Ltd.